# Immunitor

Source: https://onco.cc/companies/immunitor/  
OnCo record `immunitor` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Immunitor is a Mongolian biotech, founded in 2000, that makes oral tablet vaccines from heat-inactivated cells; its hepatocellular carcinoma vaccine hepcortespenlisimut-L went through phase 3 trials the company led.

## Summary

Immunitor, based in Ulaanbaatar and founded in 2000, develops oral tablet immunotherapies made from heat-inactivated cells, including a tuberculosis vaccine and hepcortespenlisimut-L (V5) for hepatocellular carcinoma, which it tested in phase 3 trials in Mongolia registered on ClinicalTrials.gov under Immunitor as lead sponsor.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Immunitor LLC; Immunitor Inc.
- Tags: ctgov-sponsor
- HQ: Ulaanbaatar
- Type: biotech
- Website: http://www.immunitor.mn

## Sources

- Official website: http://www.immunitor.mn
- ClinicalTrials.gov: trials led by Immunitor LLC: https://clinicaltrials.gov/search?lead=Immunitor%20LLC
- Wikidata: https://www.wikidata.org/wiki/Q50039606

## Connected records

- cancers: [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/immunitor.json